logo-loader

Omega Diagnostics Group Plc

Receive alerts
Market:
AIM
Market Cap:
£23.33 m
Price
15.52 GBX
Change
0.78%
52 weeks high
16.48
52 weeks low
8.19

In brief

Omega Diagnostics Group PLC is a United Kingdom-based holding company. The Company, along with its subsidiaries, is principally engaged in the manufacture, development and distribution of medical diagnostic products. On September 3, 2007, the Company acquired 100% of the voting shares of Genesis Diagnostics Ltd (Genesis) and Cambridge Nutritional Sciences Ltd (CNS). Genesis operates in the medical diagnostics industry developing, producing and selling a range of test kits specializing in the areas of autoimmune disease, infectious diseases and food intolerance. CNS provides a testing service for food intolerance and various other diseases.